Genmab A/S
ANTIBODIES
Last updated:
Abstract:
The present invention relates to antibodies binding to B7H4, including bispecific antibodies binding to B7H4 and CD3. The invention further provides pharmaceutical compositions comprising the antibodies and use of the antibodies for therapeutic and diagnostic procedures, in particular in cancer therapy.
Status:
Application
Type:
Utility
Filling date:
17 Mar 2021
Issue date:
23 Sep 2021